Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
SUBMITTER: Jacek Wisniewski
LAB HEAD: Jacek R Wisniewski
PROVIDER: PXD037398 | Pride | 2024-10-17
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
20191113_QX8_JRW_SA_L_SS10.raw | Raw | |||
20191113_QX8_JRW_SA_L_SS11.raw | Raw | |||
20191113_QX8_JRW_SA_L_SS12.raw | Raw | |||
20191113_QX8_JRW_SA_L_SS13.raw | Raw | |||
20191113_QX8_JRW_SA_L_SS14.raw | Raw |
Items per page: 1 - 5 of 169 |
Cell death & disease 20240831 8
The major driver oncogenes MYC, mutant KRAS, and mutant TP53 often coexist and cooperate to promote human neoplasia, which results in anticancer therapeutic opportunities within their downstream molecular programs. However, little research has been conducted on whether redundancy and competition among oncogenes affect their programs and ability to drive neoplasia. By CRISPR‒Cas9-mediated downregulation we evaluated the downstream proteomics and transcriptomics programs of MYC, mutant KRAS, and m ...[more]